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Patients with systemic autoimmune diseases show
increased incidence of atherosclerosis. However,
the contribution of proatherogenic factors to autoim-
munity remains unclear. We found that atherogenic
mice (herein referred to as LDb mice) exhibited
increased serum interleukin-17, which was associ-
ated with increased numbers of T helper 17 (Th17)
cells in secondary lymphoid organs. The environ-
ment within LDb mice was substantially favorable
for Th17 cell polarization of autoreactive T cells
during homeostatic proliferation, which was consid-
erably inhibited by antibodies directed against
oxidized low-density lipoprotein (oxLDL). Moreover,
the uptake of oxLDL induced dendritic-cell-mediated
Th17 cell polarization by triggering IL-6 production
in a process dependent on TLR4, CD36, and
MyD88. Furthermore, self-reactive CD4+ T cells that
expanded in the presence of oxLDL induced more
profound experimental autoimmune encephalomy-
elitis. These findings demonstrate that proathero-
genic factors promote the polarization and inflamma-
tory function of autoimmune Th17 cells, which could
be critical for the pathogenesis of atherosclerosis
and other related autoimmune diseases.
INTRODUCTION
Atherosclerosis is a chronic inflammatory disease manifesting in
the arterial wall and is the leading cause of mortality in the devel-
oped countries. This vascular disease is caused by imbalanced
lipid metabolism and hyperlipidemia, leading to the passage of
low-density lipoprotein (LDL) into the subendothelial area of
the artery. Within this site, LDL is oxidized to produce oxidized
LDL (oxLDL) by multiple biochemical mediators and enzymes.
Whereas LDL is captured by the LDL receptor, oxLDL is recog-
nized by different receptors, including the oxLDL receptor(LOX-1), CD36, several Toll-like receptors (TLRs), scavenger re-
ceptor SR-B1, and CD205 (Goyal et al., 2012). oxLDL is a potent
inducer of inflammatory mediators, including MCP-1, tumor
necrosis factor a (TNFa), and interleukin-1b (IL-1b), as well as
cell adhesion molecules VCAM-1 and ICAM-1, which mediate
the recruitment of macrophages and other inflammatory cells
into the subendothelial area (Hansson and Hermansson, 2011).
In addition, oxLDL can also exert anti-inflammatory functions
by activating the PPARg pathway in macrophages (Chawla
et al., 2001; Moore et al., 2001; Nagy et al., 1998). Thus, oxLDL
is a pluripotent mediator that orchestrates multiple pathways.
A number of studies have demonstrated a crucial contribution
of both innate and adaptive immunity to the pathogenesis of
atherosclerosis (Libby et al., 2013). For instance, the pathogenic
role of macrophages in atherosclerosis includes local activation
of innate immunity and recruitment of inflammatory cells into
the vascular lesions. Accordingly, blockade of monocyte and
macrophage migration into the intima by targeting chemokine
receptors (e.g., CCR2, CCR5) significantly ameliorates athero-
sclerosis in experimental animal models (Potteaux et al., 2006;
Saederup et al., 2008; Tacke et al., 2007); this approach is now
under clinical investigation (Koenen and Weber, 2010). In addi-
tion, accumulating evidence strongly suggests the involvement
of adaptive T cell responses in atherosclerosis. For instance,
the pathogenic association of T helper 1 (Th1) cell immunity
has been well documented; interferon-g (IFN-g)-producing Th1
cells are found in vascular lesions, and mice lacking the Th1
cell transcription factor T-bet, IFN-g, or the IFN-g receptor are
resistant to atherosclerosis induced by a high-fat diet (Gupta
et al., 1997; Laurat et al., 2001; Tellides et al., 2000). In addition,
recent studies have reported that IL-17-producing CD4+ T (Th17)
cells are found in the atherosclerotic lesions of bothmice and hu-
mans; however, the importance of IL-17 and Th17 cell responses
remains debatable (Danzaki et al., 2012; Eid et al., 2009; Erbel
et al., 2009). Hence, aberrant activation of both innate and adap-
tive immune responses critically contributes to the pathophysi-
ology of atherosclerosis.
The activation of innate immunity by proatherogenic factors,
including oxLDL, is well characterized; however, few studies
to date have addressed whether such factors play a role in
shaping adaptive T cell responses. In this regard, it isImmunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc. 153
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including rheumatoid arthritis (Goodson et al., 2005; Stamatelo-
poulos et al., 2009), psoriasis (Kimball et al., 2008; Krueger and
Duvic, 1994), and systemic lupus erythematosus (SLE) (Manzi
et al., 1997; Roman et al., 2003), have a substantially higher
incidence of atherosclerosis. Despite the tight link between
the T-cell-mediated autoimmune diseases and atherosclerosis,
little is known about the underlying mechanisms by which proa-
therogenic factors modulate autoimmune T cell responses, or
vice versa. Among T helper cell subsets, Th17 cells appear to
be the most pathogenic in experimental animal models of mul-
tiple sclerosis, lupus, arthritis, and psoriasis. Moreover, clinical
trials using antibodies directed against IL-17 have shown favor-
able clinical outcomes, indicating the importance of IL-17 and
Th17 cells in the pathogenesis of psoriasis and arthritis in
humans (Genovese et al., 2010; Hueber et al., 2010; Leonardi
et al., 2012).
Mice lacking the genes encoding both LDL receptor and
apolipoprotein B mRNA editing enzyme (Ldlr/Apobec1/
[LDb] mice) are hyperlipidemic and prone to atherosclerosis.
They spontaneously develop atherosclerotic plaques by the
age of 5 months when maintained on a normal chow diet (Dutta
et al., 2003; Singh et al., 2004). Unexpectedly, we observed a
preferential accumulation of effector-memory Th17 cells in the
secondary lymphoid organs and increased serum amounts of
IL-17 in the LDb mice. In vitro and in vivo studies revealed
that oxLDL, but not native LDL, profoundly induced the polari-
zation and expansion of Th17 cells by inducing IL-6 production
from dendritic cells (DCs) in a MyD88-dependent fashion.
Furthermore, myelin oligodendrocyte glycoprotein (MOG)-
reactive T cells cultured in the presence of oxLDL exhibited
enhanced Th17 cell polarization, migrated more efficiently into
the CNS, and triggered more profound experimental autoim-
mune encephalomyelitis (EAE). These findings identify proa-
therogenic factors as critical contributors to autoimmune
Th17 cell responses.
RESULTS
Atherogenic LDb Mice Have Increased IL-17
in Circulation and in the Aortic Sinus
As a first step to investigate the role of proatherogenic conditions
on the regulation of adaptive immunity, we examined metabolic
and atherosclerotic parameters of LDb mice maintained on a
regular chow diet. Consistent with previous studies (Dutta
et al., 2003; Singh et al., 2004), levels of total cholesterol and tri-
glycerides were significantly higher in LDbmice than in wild-type
mice (Figure S1A, available online). The LDb mice developed
atherosclerotic lesions in aortic sinus by 4–5 months of age (Fig-
ure 1A). The total bodyweight and the percentage of fat weight of
the LDbmicewere similar to those inwild-typemice (Figure S1B),
indicating that the atherosclerosis in the LDb mice was indepen-
dent of obesity. Because IL-17-producing cells are found in
atherosclerotic lesions in mice and humans (Eid et al., 2009; Er-
bel et al., 2009), we stained the aortic sinus with anti-IL-17 and
found that IL-17 was highly expressed in tissues derived from
LDb mice (Figure 1A). Similarly, we also found that the LDb
mice exhibited higher serum levels of IL-17 than did wild-type
mice (Figure 1B). These results demonstrate that LDb mice154 Immunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc.develop hyperlipidemia and atherosclerosis with concomitant in-
creases in IL-17 in circulation and in the aortic sinus.
To study the immune system of LDb mice, we first analyzed
various lymphoid populations in the secondary lymphoid tissues
and the thymus. The frequencies of CD4+ and CD8+ T cells in the
spleen of LDb mice were normal; however, the splenic cellularity
of LDb mice was significantly lower than that of wild-type mice
(Figures S2A and S2B). Similarly, the cellularity contained within
the peripheral lymph nodes was also decreased in LDb mice
(data not shown). Notably, LDb mice exhibited an increased
frequency of the CD44hi population among the CD4+ T cells (Fig-
ure S2C). The thymus of LDb mice showed decreased fre-
quencies of CD4+ and CD8+ cells, as well as an increased
frequency of CD4+CD8+ cells (Figure S2D). Of interest, the fre-
quency of Foxp3+ regulatory T (Treg) cells among the CD4+
T cell population was higher in the secondary lymphoid tissues
and in the thymus of LDb mice than in those of wild-type mice.
However, the absolute number of this T cell subset was signifi-
cantly lower in the LDb mice as a result of decreased cellularity
(Figures S3A–S3C). Treg cells from LDb mice and wild-type
Treg cells were equally suppressive to the proliferation of naive
CD4+ T cells in vitro (Figure S3D). Taken together, these results
indicate that proatherogenic LDb mice have decreased cellu-
larity but increased frequencies of effector-memory CD4+
T cells and Treg cells in secondary lymphoid organs.
LDb Mice Have Increased Numbers of IL-17-Producing
T Cells
Our observation of increased IL-17 in LDb mice led us to
examine the primary source of IL-17, which is most likely derived
from gd T cells or effector-memory CD4+ T cells. As shown in Fig-
ure 1C, we observed a moderate but significant increase in the
frequencies of IL-17-producing gd+ T cells in LDb mice
compared to in wild-type mice (wild-type versus LDb: in the
mesenteric lymph nodes [mLNs], 5.05 ± 0.14 versus 9.40 ±
1.29, p = 0.028; in the spleens, 8.46 ± 0.44 versus 12.13 ±
0.92, p = 0.023). Likewise, CD44hiCD4+ T cells in the spleens
and mLNs of the LDb mice showed an even more substantial in-
crease in the percentages of IL-17 producers than did those in
wild-type mice (Figures 1D and 1E). Conversely, we observed
comparable percentages of IFN-g-producing cells among the
CD44hiCD4+ T cell population between the LDb and wild-type
mice (Figures 1D and 1E). When restimulated with plate-bound
anti-CD3, CD44hiCD4+ T cells from LDb mice produced higher
amounts of IL-17 than did those from wild-type mice (Fig-
ure S4A). Despite the low cellularity, the absolute number of
IL-17-producing CD44hiCD4+ T cells in the spleen was signifi-
cantly higher in LDb mice than in wild-type mice, whereas the
absolute number of IFN-g-producing CD44hiCD4+ T cells was
comparable between the two groups (Figure 1F). To further char-
acterize the effector-memory CD4+ T cells in LDb mice, we
analyzed gene expression in CD44hiCD4+ T cells. We observed
that CD44hiCD4+ T cells from LDb mice expressed increased
mRNA for Rorc, Irf4, Il23r, Il1r1, Il21, Il22, Csf2 (encoding GM-
CSF), and Hif1a, whereas the expression of Rora, Ahr, Foxp3,
Tbx21, Ifng, and Il10 was similar between LDb and wild-type
mice (Figure S4B). Taken together, these results demonstrate
that LDb mice have a preferential increase in the Th17 cell
population.
Figure 1. LDb Mice Exhibit Increased Th17 Cell Population
(A) The expression of IL-17 in the aortic sinus in LDb or wild-typemice. Aortic sinus sections obtained from LDb or wild-typemice (4months old) were stained with
isotype control or polyclonal anti-IL-17 (red) and DAPI (blue).
(B) IL-17 levels in serum obtained from LDb or wild-type mice were measured (n = 6).
(C) IL-17 and IFN-g expression on gdTcR+ cells from the spleen or mesenteric lymph nodes (mLNs) of LDb and wild-type mice.
(D and E) IL-17 and IFN-g expression on CD44hiCD4+ T cells from the spleen, inguinal lymph nodes (iLNs), or mLNs of LDb and wild-type mice.
(F) Absolute numbers of IL-17- and IFN-g-producing CD4+ T cells in the spleens (n = 4).
Data represent three independent experiments. Data shown are themean ±SEM. *p < 0.05, **p < 0.01 in comparisonwithwild-typemice. See also Figures S1–S4.
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Responses In Vivo
The preferential increase in the Th17 cell population in LDb mice
prompted us to hypothesize that proatherogenic conditions
in vivo promote the generation of autoreactive Th17 cell re-
sponses without exogenous inflammatory stimuli. To address
this point, we employed 2D2 transgenic T cells whose T cell
receptor specifically recognizes MOG35–55, a neuroantigen
restricted to major histocompatibility complex class II mole-
cules. To rule out any possible involvement of the dysregulated
cellular populations present in the host immune system, we first
sublethally irradiated wild-type and LDbmice before transferring
total splenocytes derived from CD45.1+ 2D2 donor mice. Addi-
tionally, all recipient mice were injected intraperitoneally (i.p.)
with anti-CD25 for further depleting Treg cells given that they
are known to be resistant to irradiation (Komatsu and Hori,
2007). Within 7 days of reconstitution, the percentage of the
CD44hi population among CD45.1+2D2 donor CD4+ T cells
increased from 4.5% to 12% (Figure 2A). As expected, weobserved that the majority of CD44hi cells among the
CD45.1+CD4+ T cell population in the recipients were IFN-g pro-
ducers as a result of homeostatic proliferation. Interestingly, the
frequencies of IL-17-producing cells and IFN-g-producing cells
among the CD45.1+CD44hiCD4+ population were significantly
higher in the LDb recipient mice than in the wild-type recipients
(Figures 2A and 2B), whereas the frequency of Foxp3+ Treg cells
among donor T cells was comparable between the two groups
(Figure 2B). Moreover, when the splenocytes of the recipients
were cultured with cognate peptide, the amounts of IL-17 and
IFN-g produced were far higher in the LDb recipients (Figure 2C).
Despite the increased production of IL-17 and IFN-g by the
donor 2D2 T cells, the recipients showed no signs of CNS inflam-
mation (data not shown). Therefore, to address the importance of
the proatherogenic environment on autoimmune CNS inflamma-
tion, we immunized the recipient mice with MOG in complete
Freund’s adjuvant (CFA). As depicted in Figure 2D, the fre-
quencies of donor CD4+ T cells producing IL-17, IFN-g, or GM-
CSF were all higher in the spleens of the LDb recipients than inImmunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc. 155
Figure 2. LDb Mice Promote Th17 and Th1 Cell Responses of Self-reactive CD4+ T Cells In Vivo
Total splenocytes from 2D2 mice (CD45.1+) were intravenously (i.v.) transferred into sublethally irradiated LDb or wild-type mice (CD45.2+, n = 4). The recipients
remained without further treatment (A–C) or were additionally immunized with MOG35–55 in CFA (D and E).
(A and B) The frequencies of IL-17 or IFN-g producers among CD44hi donor CD4+ T cells and Foxp3+ cells among donor CD4+ T cells in the spleens.
(C) The amounts of IL-17 and IFN-g in the supernatant after 3-day culture of splenocytes with cognate peptide.
(D) The frequencies of IL-17+, IFN-g+, GM-CSF+, or Foxp3+ cells among donor CD4+ T cells in the spleens 2 weeks after immunization.
(E) Daily clinical scores of EAE (n = 10–12).
Data represent two independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 in comparison with wild-type mice. ##p < 0.01,
###p < 0.001 in comparison with control IgG-injected LDb mice. ND, not detected.
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tween the two groups was comparable. More importantly, clin-
ical symptoms of EAE were more severe when LDb mice
served as recipients (Figure 2E). We next sought to determine
whether the enhanced IL-17 observed in LDb recipients was
the primary factor driving increased severity of EAE. Anti-IL-17
treatment in the same model system significantly ameliorated
the clinical severity of EAE, resulting in comparable mean
clinical scores between anti-IL-17-treated LDb mice and wild-
type mice (Figure 2E). Collectively, these results demonstrate
that the proatherogenic in vivo environment of the LDb mice
triggered Th17 and Th1 cell responses in MOG-specific self-
reactive CD4+ T cells and promoted more profound CNS inflam-
mation upon autoimmune stimulation in an IL-17-dependent
manner.
Oxidized LDL Promotes DC-Mediated Th17 Cell
Polarization
The observed increase in the Th17 and Th1 cell populations in
the steady state and during homeostatic proliferation in LDb
mice prompted us to hypothesize that proatherogenic factors
promote Th17 and/or Th1 cell responses. LDb mice were previ-
ously shown to exhibit elevated amounts of LDL (Dutta et al.,156 Immunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc.2003). Moreover, LDb mice exhibited a higher concentration of
oxLDL in circulation than did wild-type animals (Figure 3A). To
address whether these proatherogenic factors modulate T
helper cell polarization, we employed a T cell:DC coculture sys-
tem in which stimulation with LPS plus TGF-b and soluble anti-
CD3 induces the polarization of Th17 cells from naive CD4+
T cells (Veldhoen et al., 2006). When native LDL was added
instead of LPS, we observed little change in the frequency of
IL-17-producing T cells (<2%). In contrast, the addition of oxLDL
(thiobarbituric-acid-reactive substance [TBARS] values = 25–35)
greatly increased the frequency of IL-17-producing T cells in the
presence of TGF-b (Figure 3B). CD4+ T cells cultured under this
condition expressed significantly increased amounts of Th17 cell
signature genes, including Il17, Il17f, Il21, Il22, Rorc, Rora, Irf4,
Batf, Ccr6, Il23r, and Il1r1 transcripts, whereas the transcript
levels of Il10 and Ahr were lower than those of CD4+ T cells
cultured without oxLDL (Figure 3C). Similarly, the addition of
acetylated LDL also promoted the generation of IL-17-producing
CD4+ T cells (Figures S5A and S5B). Conversely, neither LDL nor
oxLDL increased the frequency of IFN-g-producing Th1 cells
(Figure 3B, upper panels). Furthermore, the addition of LDL or
oxLDL with IL-12 had no effect on Th1 cell differentiation or the
expression of Ifng or Tbx21 transcripts (Figures 3D and 3E). In
Figure 3. Oxidized LDL Promotes DC-Mediated Th17 Cell Differentiation In Vitro
(A) Concentration of oxLDL in serum at the age of 2- or 4-month-old wild-type and LDb mice (n = 4–5).
(B–E) Purified naive CD4+ T cells were cocultured with bone-marrow-derived DCs (BMDCs) in the presence of soluble anti-CD3 under the indicated conditions for
4 days.
(B and D) The frequencies of IL-17 or IFN-g producers among CD4+ T cells.
(C and E) The levels of mRNA transcripts of the indicated genes.
Data are representative of at least three independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S5
and S6.
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Foxp3+ Treg cells from naive T cells in vitro (Figure S6). Thus,
modified LDL, but not native LDL, induced DC-mediated Th17
cell differentiation while minimally affecting Th1 cell differentia-
tion in vitro.
IL-6, IL-1, and IL-23 have been shown to be crucial in Th17 cell
lineage commitment. To address possible mechanisms for the
observed oxLDL-mediated Th17 cell differentiation, we added
neutralizing antibodies to IL-6, IL-23p19, IL-12p40, or IL-1R1
during a similar set of coculture experiments. As shown in Fig-
ures 4A and 4B, neutralization of IL-6 almost completely abol-
ished the generation of IL-17-producing CD4+ T cells. Addition
of IL-1R1-blocking antibody also inhibited the polarization of
Th17 cells, but the intensity of such inhibition varied from 30%
to 96%. Alternatively, antibodies against IL-23p19 or IL-12p40
only marginally affected the differentiation of Th17 cells (Figures
4A and 4B). To further examine the involvement of IL-6, we stim-
ulated DCs with native LDL or oxLDL and found that oxLDL trig-
gered the production of IL-6, whereas native LDL failed to do so
(Figure 4C). Interestingly, the capacity of oxLDL to induce IL-6
was dependent on the extent of oxidation; oxLDL with low and
medium TBARS values (5–15 and 25–35, respectively) induced
similar degrees of IL-6 production from DCs, whereas oxLDL
with high TBARS values (50–70) failed to do so (Figure 4D). Thelevels of endotoxin in the LDL and oxLDL used were below the
detectable range in an limulus amebocyte lysate (LAL) assay
(<0.5 EU/mg). Moreover, the addition of polymyxin B did not
affect the production of IL-6 (Figure 4C), ruling out any possible
role of endotoxin contamination. Because of the potency of
oxLDL with medium TBARS values in inducing IL-6 from DCs,
we utilized this reagent for the remaining studies.
Primary DCs in LDb mice showed a similar phenotype to that
of oxLDL-stimulated DCs in vitro. CD11c+ DCs purified from the
spleen of LDb mice expressed higher amounts of Il6, Il1b, and
Il23amRNA transcripts than did those from wild-type mice (Fig-
ure 4E), suggesting that the proatherogenic in vivo condition,
potentially mediated through oxLDL, stimulated DCs to produce
a variety of the Th17-cell-promoting cytokines.
TLR4, CD36, and MyD88 Are Required for the Th17 Cell
Differentiation Induced by oxLDL
Cell-surface molecules identified as receptors for oxLDL include
LOX-1, CD36, TLR4, SR-B1, and CD205. In addition, a recent
study revealed MyD88 as a downstream adaptor to promote
sterile inflammation in macrophages in response to oxLDL and
amyloid-b peptide (Stewart et al., 2010). Thus, we askedwhether
Th17 cell differentiation induced by oxLDL requires MyD88
expression in DCs. As shown in Figure 5A, MyD88-deficientImmunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc. 157
Figure 4. Oxidized LDL Induces the Production of Th17-Cell-Promoting Cytokines
(A and B) Naive CD4+ T cells were cocultured with BMDCs under the indicated conditions in the presence or absence of the indicated antibodies for 4 days. (A)
The frequencies of IL-17 or IFN-g producers among CD4+ T cells. (B) IL-17 production by CD4+ T cells after stimulation with plate-bound anti-CD3 (1 mg/ml).
(C and D) IL-6 production by BMDCs after stimulation with 20 mg/ml LDL or oxLDL (medium TBARS values) (C) or with 20 mg/ml oxLDL with high, medium, or low
TBARS values (D).
(E) Relative mRNA expression of the indicated genes in the freshly purified CD11c+ DCs from the spleens of LDb and wild-type mice.
Data represent at least three independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. ND, not detected.
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oxLDL and TGF-b. Similarly, the amounts of IL-6 produced by
MyD88-deficient DCs (both bone-marrow-derived DCs [BMDCs]
and primary DCs) were far lower than those produced by wild-
type DCs (Figure 5B).
Because MyD88 was necessary for the differentiation of Th17
cells and IL-6 production from DCs induced by oxLDL, we hy-
pothesized that TLR4 acts as a receptor for oxLDL during this
process. In addition, CD36 is known to be required for the pro-
duction of IL-1b from macrophages in response to oxLDL (Ja-
nabi et al., 2000; Stewart et al., 2010). To test which factors
are important for oxLDL-mediated Th17 cell differentiation, we
examined the function of TLR4 and CD36. The uptake of a fluo-
rescent-dye-labeled oxLDL (Dil-oxLDL), measured by the mean
fluorescence intensity of Dil-oxLDL present in DCs, was far less
efficient in both TLR4- and CD36-deficient DCs than in wild-type
cells (Figures 5C and 5D). Moreover, oxLDL induced IL-6 pro-
duction from primary DCs and BMDCs, but not when TLR4 or
CD36 was absent (Figures 5E and 5F). Consequently, compared
to CD4+ T cells cultured with wild-type DCs, CD4+ T cells
cultured with TLR4- or CD36-deficient DCs in the presence of
oxLDL and TGF-b induced significantly less IL-17 and Th17
cell signature genes while triggering increased expression of
Foxp3 (Figures 5G and 5H). It is noteworthy that CD36-deficient
DCs induced normal Th17 cell differentiation when stimulated158 Immunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc.with LPS and TGF-b, further indicating that the Th17-cell-pro-
moting capacity of oxLDL is mechanistically different from that
of endotoxin. Taken together, these results demonstrate that
oxLDL requires TLR4 and CD36, as well as the intracellular
adaptor MyD88, to induce IL-6 and subsequent Th17 cell differ-
entiation in our experimental setting.
MOG-Reactive T Cells that Expand in the Presence
of oxLDL Induce Severe EAE
We next determined whether oxLDL can promote autoantigen-
specific CD4+ T cell responses in vivo. To this end, we immu-
nized B6.SJL mice with MOG35–55 emulsified in CFA. One
week later, we obtained lymphoid cells from the draining lymph
nodes (LNs) before restimulating them with the same peptide
ex vivo. In some wells, we additionally added IL-23 and/or
oxLDL. As depicted in Figure 6A, the addition of oxLDL signifi-
cantly increased the frequency of IFN-gIL-17+ cells and the pro-
duction of IL-17 and IFN-g from the MOG-reactive CD4+ T cells.
oxLDL also slightly increased the frequency of IFN-g+IL-17+, but
not IFN-g+IL-17, T cells (Figure 6A). Thus, the enhanced pro-
duction of IFN-g was most likely due to an increase in Th17 cells
coexpressing IFN-g rather than to the expansion of Th1 cells.
Compared to CD4+ T cells stimulated with IL-23 alone, CD4+
T cells stimulated with IL-23 and oxLDL expressed significantly
higher Il17, Ifng, Csf2, Ccr6, Il1r1, and Il23r mRNA transcripts,
Figure 5. TLR4, CD36, and MyD88 Are Essential for oxLDL-Mediated Differentiation of Th17 Cells
(A) The frequencies of IL-17 or IFN-g producers among CD4+ T cells cocultured with wild-type or Myd88/ DCs under the indicated conditions.
(B) Production of IL-6 from freshly isolated DCs or BMDCs after stimulation with oxLDL (20 mg/ml).
(C and D) The uptake of Dil-oxLDL by DCs freshly isolated from the spleens of wild-type, Tlr4/, or Cd36/ mice.
(E and F) Production of IL-6 by freshly isolated or BMDCs from wild-type, Tlr4/ (E), or Cd36/ (F) mice (n = 3–4) after stimulation with oxLDL.
(G andH) NaiveCD4+ T cells were coculturedwith BMDCs fromwild-type, Tlr4/, orCd36/mice plus soluble anti-CD3 and TGFb in the presence or absence of
LPS or oxLDL for 4 days. The production of IL-17 by T cells (G) and the levels of mRNA transcripts of the indicated genes (H) are shown.
Data represent at least two independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01.
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a-subunit of VLA-4), and Itgb2 (encoding the b-subunit of
LFA-1) transcripts remained comparable (Figure 6B).
To further investigate whether oxLDL stimulation affects the
pathogenicity of MOG-reactive CD4+ T cells, we adoptively
transferred the expanded MOG-reactive CD4+ T cells
(CD45.1+/+) into C57BL/6mice before the recipients were subcu-
taneously (s.c.) immunized with MOG35–55 in CFA. Notably, the
clinical severity during the early and peak phases of EAE was
significantly higher in the recipients of the T cells stimulated
with IL-23 plus oxLDL than in those of the IL-23-stimulated
T cells (Figure 6C). In the draining LNs, donor T cells that were
previously cultured with IL-23 plus oxLDL exhibited higher per-
centages of the IL-17- and IFN-g-producing population than
did those in the recipients of T cells stimulated with IL-23 alone
(Figure S7). Importantly, we observed higher numbers of infil-
trating CD4+ T cells in the CNS in the former group, mainly as
a result of higher numbers of CD45.1+ donor T cells, whereasthe numbers of host CD4+ T cells were comparable (Figures
6D and 6E). The percentages of IL-17 and IFN-g producers
among the CD45.1+ donor T cell population in the CNS were
similar between these two groups (Figures 6D and 6F). Neverthe-
less, because of the higher frequencies of donor T cells in the
CNS, the absolute numbers of IL-17 and IFN-g producers were
significantly higher in the recipients of T cells stimulated with
IL-23 plus oxLDL (Figure 6F). Collectively, these results indicate
that the addition of oxLDL during the ex vivo expansion of MOG-
reactive CD4+ T cells rendered the T cells more pathogenic in
inducing autoimmune CNS inflammation.
oxLDL Plays a Crucial Role in the Enhanced
Autoreactive Th17 Cell Responses in LDb Mice
Our findings that LDb mice had an increased Th17 cell
population and elevated amounts of oxLDL in circulation (Fig-
ures 1 and 3A), that oxLDL induced enhanced Th17 cell re-
sponses in a DC-mediated differentiation of Th17 cells in vitroImmunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc. 159
Figure 6. MOG-Reactive T Cells that Expand in the Presence of oxLDL Induce Enhanced EAE
Lymphoid cells from the draining LNs of B6.SJLmice (CD45.1+) that were previously immunizedwithMOG35–55 in CFAwere restimulated with the same peptide in
the presence or absence of oxLDL and IL-23 for 5 days.
(A and B) Production of IL-17 and IFN-g by CD4+ T cells (A) and mRNA levels of the indicated genes (B).
(C–F) The ex-vivo-expanded MOG35–55-reactive CD4
+ T cells (1 3 106 cells/transfer) were i.v. transferred into congenic recipients (CD45.2+), which were then
immunized with MOG35–55 in CFA (n = 9–10). (C) The clinical severity of EAE. (D and F) the frequencies and absolute numbers of IL-17- or IFN-g-producing donor
CD4+ T cells in the CNS tissues. (E) The proportion and absolute numbers of CD4+ and CD11b+ cells.
Data represent three independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S7.
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autoreactive T cells ex vivo (Figure 6) led us to hypothesize that
oxLDL plays a crucial role in autoimmune Th17 cell differentia-
tion in vivo. To test this hypothesis, we examined whether
neutralization of oxLDL suppresses the differentiation of autor-
eactive Th17 cells in LDb mice by employing the 2D2 spleno-
cyte transfer model used in Figure 2. The LDb recipient mice
were additionally administered neutralizing anti-oxLDL (clone
E06) or isotype control Ab (mouse IgM). Clone E06 anti-oxLDL
was previously shown to block the uptake of oxLDL by macro-
phages (Ho¨rkko¨ et al., 1999; Palinski et al., 1996). As depicted in
Figures 7A and 7B, the frequency of IL-17 producers among
CD45.1+CD44hiCD4+ donor T cells was significantly decreased
in LDb recipients treated with anti-oxLDL than in control
Ab-treated LDb recipients. Conversely, the frequency of IFN-g
producers in the LDb recipients was not remarkably affected
by anti-oxLDL treatment (Figures 7A and 7B). The percentage
of IL-17+ among CD44hiCD4+ donor T cells in the anti-oxLDL-
treated LDb mice was still higher than that of wild-type mice,
although the difference did not reach statistical significance.160 Immunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc.Gene expression analysis showed that anti-oxLDL treatment
greatly decreased the mRNA expression of Il17, Il23r, and
Rorc while not affecting the expression of Ifng, Tbx21, or
Foxp3 (Figure 7C).
To further examine the influence of oxLDL in antigen-specific
Th1 and Th17 cell responses, we restimulated splenocytes
derived from the recipients with MOG peptide. Once again, the
production of IL-17 and IFN-g was higher in LDb recipients
than in wild-type recipients. However, the amount of IL-17 pro-
duced by T cells was substantially lower in anti-oxLDL-treated
LDb recipients than in control Ab-treated LDb recipients (Fig-
ure 7D). Notably, IL-17 production by T cells from anti-oxLDL-
treated LDb recipient mice was still significantly higher than
that from wild-type recipients, indicating that anti-oxLDL treat-
ment did not completely abolish the enhancement of Th17 cell
responses in LDb mice. However, anti-oxLDL could not influ-
ence IFN-g production by the donor T cells in the LDb recipients.
These results together demonstrate that oxLDL plays a crucial
role for the enhanced autoreactive Th17 cell responses present
in proatherogenic LDb mice.
Figure 7. Anti-oxLDL Diminishes Autoreactive Th17 Cell Responses in LDb Mice
Total splenocytes from 2D2mice (CD45.1+) were i.v. transferred into sublethally irradiated LDb or wild-typemice (CD45.2+, n = 6) at day 0. LDb recipients were i.p.
injected with anti-oxLDL or isotype control antibody at days 1, 1, and 3.
(A and B) The frequencies of IL-17 or IFN-g producers among CD44hi donor CD4+ T cells in the spleens.
(C) Transcript levels of the indicated genes.
(D) The amounts of IL-17 and IFN-g in the supernatant after 3-day culture of splenocytes stimulated with MOG35–55 peptide.
Data represent two independent experiments. Data shown are the mean ± SEM. *p < 0.05, **p < 0.01. ND, not detected.
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Despite a strong association between atherosclerosis and
T-cell-mediated systemic autoimmune diseases in humans, the
role of proatherogenic factors in regulating adaptive T cell re-
sponses and autoimmunity is unclear. Our findings demonstrate
that proatherogenic conditions promote autoimmune Th17 cell
responses because (1) nonobese hyperlipidemic LDb mice ex-
hibited a preferential increase in the Th17 cell population in the
steady state and during homeostatic proliferation, (2) LDb mice
were more susceptible to CNS inflammation in an IL-17-depen-
dent manner than were wild-type mice in an adoptive-transfer
EAE model, (3) oxLDL, but not native LDL, promoted DC-medi-
ated Th17 cell polarization, (4) MOG-reactive T cells that
expanded in the presence of oxLDL triggered more profound
EAE, and (5) neutralizing anti-oxLDL significantly inhibited Th17
cell differentiation of autoreactive T cells in LDb mice. Hence,
the present study has revealed amodulation of adaptive T cell re-sponses by proatherogenic factors, which might explain the as-
sociation between atherosclerosis and systemic autoimmune
diseases in humans.
Increased concentration of LDL is one of the major proathero-
genic factors in mediating vascular inflammation. Here, we
demonstrated that LDb mice exhibited a significantly higher
amount of oxLDL in circulation than did wild-type mice; this
was evident as early as 2 months of age. Among several identi-
fied receptors for oxLDL, the CD36-TLR4-TLR6-MyD88-IRAK4-
NFkB axis has been identified by recent studies as a signaling
pathway mediating the production of proinflammatory cytokines
and chemokines in macrophages in response to modified LDL
(Janabi et al., 2000; Kim et al., 2011; Stewart et al., 2010). By
contrast, it has been also reported that CD36-mediated uptake
of oxLDL inhibits the production of proinflammatory cytokines
from macrophages through the activation of PPARg (Chawla
et al., 2001; Moore et al., 2001; Nagy et al., 1998). We found
that both TLR4 and CD36 were required for the uptake of oxLDLImmunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc. 161
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Proatherogenic Factors in Th17 Cell Autoimmunityand IL-6 production by DCs. Furthermore, anti-oxLDL signifi-
cantly suppressed the differentiation of self-reactive 2D2
T cells into Th17 cells in LDb mice in vivo. Thus, we propose
that oxLDL promotes DC-mediated Th17 cell polarization in a
TLR4-, CD36-, and MyD88-dependent manner.
Atherosclerosis has been considered an autoimmune disease,
given that CD4+ T cells reactive to self-antigens such as heat-
shock protein 60 and oxLDL were found in atherosclerotic
plaques in humans (Grundtman and Wick, 2011; Hansson and
Hermansson, 2011). In addition, a few recent studies have sug-
gested a possible link between proatherogenic factors and in-
flammatory T cell responses. For instance, obese mice on a
high-fat diet are more susceptible to EAE (Winer et al., 2009).
Moreover, when human peripheral-blood mononuclear cells
were stimulated with oxLDL, the ratio of Th17 cells to Treg cells
was increased (Li et al., 2010). In the present study, we found that
a proatherogenic environment within LDb mice triggered the dif-
ferentiation of self-reactive 2D2 T cells into Th17 and Th1 cells
more efficiently and promotedmore profound CNS inflammation
in an IL-17-dependent manner than did the same environment in
wild-typemice. The finding that anti-oxLDL significantly inhibited
the differentiation of Th17 cells in LDb mice strongly suggests a
pathogenic role of oxLDL in promoting autoimmune Th17 cell re-
sponses in vivo. However, it is not clear whether oxLDL is the
only major proatherogenic factor responsible for driving Th17
cell responses in LDbmice or whether oxLDL is sufficient to drive
autoimmune Th17 cells in vivo. We speculate that multiple proa-
therogenic factors provide inflammatory signals to promote
autoimmune Th17 cell responses in atherosclerosis-prone
mice in vivo. For instance, a recent study demonstrated that acti-
vation of the NLRP3 inflammasome by cholesterol crystals is
required for atherogenesis (Duewell et al., 2010). Moreover,
free fatty acids that are thought to be pathogenic in diabetes
and atherosclerosis are known to signal through the inflamma-
some or TLR4 to trigger the expression of proinflammatory cyto-
kines such as IL-1b, TNFa, and IL-6 (Shi et al., 2006; Wen et al.,
2011). Hence, one can surmise that these proatherogenic factors
collaboratively trigger the production of IL-1b and other proin-
flammatory cytokines and thus promote Th17 cell responses
in vivo. Further studies will be needed for determining in vivo
function of oxLDL and other atherogenic factors in autoimmune
T cell responses.
The increased Th1 cell population observed in irradiated LDb
mice was possibly a result of lymphopenia-dependent homeo-
static proliferation, which can cause the conversion of Th17 cells
into Th1 cells in a lymphopenic host (Martin-Orozco et al., 2009;
Nurieva et al., 2009). Alternatively, it is possible that proathero-
genic factors other than oxLDL were involved in the expansion
of Th1 cells given that anti-oxLDL did not inhibit Th1 cell differen-
tiation. The enhanced autoreactive Th17 cell responses
observed in the LDb mice were probably not due to the
increased Foxp3+ Treg cells given that Treg cells in the recipient
mice were depleted prior to irradiation and reconstitution. Thus,
the role of proatherogenic conditions on Treg and Th1 cells is not
clear at themoment, and further studies will be needed for inves-
tigating these pathways.
Functionally, MOG-reactive CD4+ T cells that expanded in the
presence of oxLDL induced more profound EAE when trans-
ferred into naive congenic mice with higher numbers of infiltrated162 Immunity 40, 153–165, January 16, 2014 ª2014 Elsevier Inc.donor CD4+ T cells in the CNS. Consistent with this notion,
coculture with oxLDL also upregulated the expression of Ccr6,
Il23r, and Il1r1 in T cells, all of which are known to be essential
for the migration of Th17 cells into the target tissue where auto-
immune inflammation occurs (Chung et al., 2009; Langrish et al.,
2005; McGeachy et al., 2009; Yamazaki et al., 2008). The syner-
gistic effect of IL-23 and oxLDL in promoting the Th17 cell line-
age program suggests that these two factors might exert similar
but nonredundant functions in mediating the expansion or func-
tional maturation of initially committed autoreactive Th17 cells.
Several recent studies have also proposed the anti-inflamma-
tory functions of cholesterols through the activation of transcrip-
tion factor LXR in macrophages and CD4+ T cells (Cui et al.,
2011; Spann et al., 2012). Thus, lipid species in a hyperlipidemic
individual possibly exert both pro- and anti-inflammatory re-
sponses in vivo depending on their metabolic and chemical
state. Given the observation that DCs from LDb mice expressed
higher amounts of Il1b, Il6, and Il23a transcripts, we speculate
that the overall effect of hyperlipidemia in the LDb mice was
proinflammatory. Whether atherogenic factors directly stimulate
autoreactive T cells is not clear at this time. In the present study,
addition of oxLDL during in vitro stimulation of naive CD4+ T cells
under the inducible Treg cell condition did not affect the expres-
sion of Foxp3. Future studies will be required for dissecting any
T-cell-intrinsic effects of proatherogenic factors during the
development of atherosclerosis and autoimmunity in vivo.
In summary, the present study unveils a function of proathero-
genic factors in modulating autoimmune Th17 cell responses in
mice. Our findings might explain why patients with atheroscle-
rosis exhibit increased incidence of various autoimmune
disorders.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, B6.SJL (CD45.1+/+), Myd88/, Tlr4/, Cd36/ and 2D2 TcR
transgenic mice were purchased from the Jackson Laboratory (Bar Harbor).
LDb mice (Ldlr/Apobec1/ mice on a C57BL/6 genetic background) were
generated as described (Dutta et al., 2003). CD45.1 3 2D2 mice were gener-
ated by the interbreeding of B6.SJL and 2D2 TcR-transgenic mice. All mice
were bred and maintained in the specific pathogen-free facility at the vivarium
of the Institute of Molecular Medicine. All animal experiments were performed
according to protocols approved by the Institutional Animal Care and Use
Committee of the University of Texas at Houston.
Immunohistochemical Analysis
Mouse aortic sinus tissue slides were fixed in 4% paraformaldehyde and were
incubated with goat anti-IL-17 (sc-6077, Santa Cruz Biotechnology) or isotype
control. The slides were further incubated with Alexa594-conjugated anti-goat
IgG (Invitrogen) and were then mounted with mounting medium containing
DAPI (Vector). The slides were examined with a Zeiss Axio Observer.D1m fluo-
rescence microscope with DAPI or Texas Red filters.
Flow Cytometry
Lymphoid cells were obtained and stained with PerCp-Cy5.5 anti-CD4
(GK1.5), APC anti-CD44 (IM7), Alexa647 anti-gdTcR (UC7-13D5), Alexa488
anti-CD11b (1J70), PE anti-CD25 (PC61), Alexa488 anti-CD62L (MEL14), or
PacificBlue anti-CD45.1 (A20). Intracellular cytokine staining was performed
as previously described (Chung et al., 2009) with the use of PE anti-IL-17A
(TC11-18H10.1), Alexa488 anti-IFN-g (XMG1.2), FITC anti-GM-CSF (MP1-
22E9), or Alexa488 anti-Foxp3 (FJK-16 s). For the oxLDL-uptake assay, pri-
mary DCs were isolated from the spleen of wild-type, Tlr4/, or Cd36/
mice with the use of CD11c microbeads (Miltenyi Biotec). The purified DCs
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3,3,30,30-tetramethyl-indocarbocyanine perchlorate (Dil-oxLDL, Biomedical
Technologies) for 30 min or 2 hr. After washing, the uptake of Dil-oxLDL by
the DCs was analyzed by flow cytometry.
Cell Isolation and Differentiation
BMDCs from Myd88/, Tlr4/, Cd36/, or wild-type mice were cultured
with naive CD4+ T cells sorted by fluorescence-activated cell sorting in the
presence of 0.3 mg/ml soluble anti-CD3, TGF-b (3 ng/ml), or IL-12 (10 ng/ml)
for inducing Th17 or Th1 cell polarization. In some wells, 20 mg/ml LDL,
20 mg/ml oxLDL (TBARS = 2535), 100 ng/ml LPS, or 1 mg/ml Polymyxin B
(Sigma-Aldrich) was added. For cytokine blockade experiments, anti-IL-1R1
(JAMA147), anti-IL-6 (MP5-20F3), anti-IL-23p19 (G23-8), or anti-IL-12p40
(C17.8) was additionally added (all 5 mg/ml). Four days after the culture, the
production of cytokines and the expression of genes were analyzed by ELISA,
flow cytometry, or quantitative RT-PCR with primers described in Table S1.
ELISA
The amounts of IL-17, IFN-g, or IL-6 in cultured supernatant or serum were
measured with a sandwich ELISA kit (BioLegend). In some experiments, pri-
mary DCs were freshly isolated from the spleens of C57BL/6, Myd88/,
Tlr4/, and Cd36/mice with the use of anti-CD11c beads. The isolated pri-
mary DCs and BMDCs (13 106 cells/ml) were stimulated with 100 ng/ml LPS,
20 mg/ml LDL, or three types of oxLDLs with differential oxidation extents
(low TBARS [5–15], medium TBARS [25–35], or high TBARS [50–70]; all
from Biomedical Technologies). The endotoxin levels of oxLDL and LDL
were < 0.5 EU/mg LDL, as measured by an LAL assay (Associates of Cape
Cod). Twenty-four hours after stimulation, the levels of IL-6 in the supernatant
were measured by ELISA. The oxLDL levels in mouse serum were measured
with an ELISA kit (Cusabio Biotech) according to the manufacturer’s
instruction.
Induction and Analysis of EAE
Lymphoid cells from the spleens and draining LNs were isolated from B6.SJL
mice immunized s.c. with 300 mgMOG35–55 emulsified in 100 ml CFA containing
killed M. tuberculosis (5 mg/ml) at day 7 after immunization and were then
cultured in vitro (5 3 106 cells/ml) with 20 mg/ml MOG35–55 and 20 ng/ml
IL-23 in the presence or absence of 20 mg/ml oxLDL (TBARS = 2535) for
5 days. CD4+ T cells were purifiedwith anti-CD4microbeads and intravenously
(i.v.) transferred into C57BL/6 mice at day 0 (1 3 106 cells/transfer). In some
experiments, total splenocytes obtained from CD45.1+2D2 mice were i.v.
transferred (1 3 107 cells/transfer) into sublethally irradiated (750 rad) and
anti-CD25-treated (day 3, 300 mg/mice) LDb or wild-type mice (day 0).
Some LDb recipients were additionally injected with 200 mg of anti-IL-17
(17F3) or isotype control (i.p.) every 3 days starting on day 1. All recipient
mice were s.c. immunized with MOG35–55 (300 mg) emulsified in 100 ml CFA
containing killed M. tuberculosis (0.5 mg/ml) (day 0) and received 500 ng of
pertussis toxin i.p. on days 0 and 2. The EAE clinical score was assessed as
previously described (Chung et al., 2009).
Homeostatic Proliferation Study
Splenocytes obtained from CD45.1 3 2D2 mice were transferred (1 3 107
cells/transfer) i.v. into sublethally irradiated (750 rad) LDb or wild-type recipient
mice at day 0. In some experiments, LDbmice were injected i.p. with 250 mg of
anti-oxLDL (clone: E06, Avanti Polar Lipids) or mouse IgM as isotype control at
days 1, 1, and 3. Seven days after the transfer, splenocytes were harvested
from the recipient mice. IL-17 and IFN-g expression among CD45.1+
CD44hiCD4+ T cells and Foxp3 expression among CD45.1+CD4+ T cells
were analyzed by flow cytometry. Splenocytes (2.5 3 106 cells/ml) obtained
from the recipients were stimulated with 20 mg/ml MOG35–55 for 3 days, and
the amounts of IL-17 and IFN-g in the supernatant were measured by ELISA.
Statistics
Data were analyzed with GraphPad Prism 5 (GraphPad Software). Statistics
were calculated with the two-tailed Student’s t test or a Mann-Whitney
U-test. p values < 0.05 were considered statistically significant. *p < 0.05,
**p < 0.01, ***p < 0.001.SUPPLEMENTAL INFORMATION
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